Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Core Laboratories (CLB) Equity Ratio (2022 - 2025)

Core Laboratories' Equity Ratio history spans 4 years, with the latest figure at 0.47 for Q4 2025.

  • For Q4 2025, Equity Ratio rose 10.61% year-over-year to 0.47; the TTM value through Dec 2025 reached 0.47, up 10.61%, while the annual FY2025 figure was 0.47, 10.61% up from the prior year.
  • Equity Ratio reached 0.47 in Q4 2025 per CLB's latest filing, up from 0.46 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.47 in Q4 2025 to a low of 0.3 in Q2 2022.
  • Average Equity Ratio over 4 years is 0.39, with a median of 0.4 recorded in 2024.
  • Peak YoY movement for Equity Ratio: grew 21.27% in 2023, then grew 7.45% in 2025.
  • A 4-year view of Equity Ratio shows it stood at 0.32 in 2022, then increased by 20.58% to 0.38 in 2023, then rose by 10.12% to 0.42 in 2024, then grew by 10.61% to 0.47 in 2025.
  • Per Business Quant, the three most recent readings for CLB's Equity Ratio are 0.47 (Q4 2025), 0.46 (Q3 2025), and 0.44 (Q2 2025).